The Goal Is Not Always Zero Seizures
When your dog is diagnosed with epilepsy, the instinct is to demand complete seizure elimination. But that is not always realistic — and chasing an impossible target can lead to over-medication with serious side effects. The International Veterinary Epilepsy Task Force defines treatment success as a 50% or greater reduction in seizure frequency with acceptable quality of life — not necessarily zero events.
Clinical goals usually balance four factors: frequency reduction, severity reduction, safer recovery between events, and an acceptable side-effect burden. Without clearly defined goals from the start, treatment changes become reactive and inconsistent. Every household managing seizure care needs to know what success actually looks like for their dog.
Understanding Canine Epilepsy Medications
The most commonly used antiepileptic drugs (AEDs) in dogs include:
Phenobarbital: The oldest and most widely used canine AED. Effective in approximately 60-80% of epileptic dogs. Requires regular serum level monitoring (therapeutic range: 15-45 mcg/mL) and periodic liver enzyme assessment because chronic use can cause hepatotoxicity. Side effects include increased appetite, weight gain, sedation, ataxia, and polyuria/polydipsia.
Potassium bromide (KBr): Often used as a second-line agent or combined with phenobarbital. Slower onset of action (requires weeks to reach steady state). Does not undergo hepatic metabolism, making it safer for dogs with liver disease. Side effects include GI upset, sedation, and rare pancreatitis risk. Serum levels should be maintained between 1,000-3,000 mcg/mL (monotherapy) or 1,000-2,000 mcg/mL (combined with phenobarbital).
Levetiracetam (Keppra): Increasingly popular as adjunctive therapy. Minimal hepatic metabolism and relatively wide safety margin. The extended-release formulation allows twice-daily dosing. Side effects are generally mild (sedation, inappetence) but efficacy as monotherapy is less established than phenobarbital.
Zonisamide: A sulfonamide-related AED used as adjunctive therapy. Metabolized hepatically and renally. Side effects include sedation, ataxia, and rare idiosyncratic hepatotoxicity. Requires monitoring of liver and kidney function.
Imepitoin: Approved in some countries for canine epilepsy. Lower potency than phenobarbital but fewer metabolic side effects. May be appropriate for mild epilepsy cases.
Get the Baseline Right Before You Start
High-quality monitoring starts with baseline context that allows meaningful comparison over time:
- Seizure history pattern: Document frequency, duration, type (focal vs. generalized), clustering pattern, and any identifiable triggers for at least 4-8 weeks before starting medication if seizures are infrequent enough to allow this safely.
- Neurologic exam findings: Baseline neurological assessment helps distinguish medication side effects from disease progression later.
- Relevant lab values: Complete blood count, chemistry panel (including liver enzymes — ALT, ALP, GGT), and thyroid panel (phenobarbital can suppress thyroid function). These baselines are essential for detecting medication-induced organ effects.
- Comorbid disease context: Dogs with kidney disease or liver disease require modified drug selection and monitoring intensity.
Baseline quality improves later decisions when control changes or side effects emerge.
Missed Doses Are Not Minor — They Are Dangerous
Irregular dosing is one of the most common preventable destabilizers in seizure management. Anticonvulsant drugs maintain steady-state serum concentrations that provide continuous seizure threshold protection. Missed doses create windows of subtherapeutic blood levels during which breakthrough seizures — including dangerous cluster seizures — can occur.
Build adherence systems:
- Fixed dosing schedule tied to daily routines that do not vary (meals, waking, bedtime) with alarms set for exact timing.
- Shared household reminder process — all caregivers must know the schedule, the drug names and doses, and the protocol for a missed dose.
- Written missed-dose instructions from your veterinarian posted where medications are stored. General guidance: give the missed dose as soon as remembered unless it is nearly time for the next dose. Never double-dose.
- Medication refill buffer — maintain at least a 2-week supply at all times. Running out of medication because a refill was delayed is a preventable crisis.
Consistency reduces avoidable cluster risk and makes serum level interpretation more reliable.
Your Household Needs a Written Seizure Action Plan
Every household should keep a one-page response plan posted in a visible location:
- Emergency contact numbers (regular vet, emergency vet, poison control)
- Emergency threshold definitions from your veterinarian (seizure lasting more than 5 minutes, two or more seizures within 24 hours, seizure during which the dog stops breathing)
- Exact step order during and after an event: keep the dog away from furniture and stairs, do not put hands in the mouth, time the seizure with a phone, note time and duration
- Medication list and doses — including any rectal diazepam or intranasal midazolam prescribed for emergency home use
- Post-ictal care instructions: keep the environment quiet and dark, prevent the dog from injuring itself during the confused recovery period, monitor for repeat events
In high-stress moments, written sequence beats memory. Every household member and regular caretaker (pet sitter, dog walker) should know where this plan is posted.
Regular Bloodwork Is Part of the Treatment
Many antiepileptic protocols require periodic laboratory assessment for:
- Serum drug levels: Phenobarbital levels should be checked 2-4 weeks after starting or changing dose, then every 6 months during stable maintenance. Sample timing matters — trough levels (taken just before the next dose) provide the most useful information. Bromide levels take longer to reach steady state (8-12 weeks) and should be checked accordingly.
- Hepatic monitoring: Phenobarbital can cause progressive liver enzyme elevation and, rarely, clinically significant hepatotoxicity. Bile acids testing provides more sensitive hepatic function assessment than ALT/ALP alone.
- Thyroid function: Chronic phenobarbital use commonly suppresses total T4 levels. Free T4 by equilibrium dialysis is more reliable for assessing true thyroid status in dogs on phenobarbital.
- Renal function: For dogs on potassium bromide or with concurrent kidney disease, kidney values should be monitored regularly.
- Interaction risk with other therapies: Some drugs alter AED metabolism. Always inform your veterinarian about all medications and supplements your dog is receiving.
Monitoring intervals should be defined at treatment start and documented in your care plan.
Why “In Range” Does Not Always Mean “Under Control”
Drug level results are useful only with clinical context. Interpretation errors often include:
- Acting on a number without seizure trend data — a “therapeutic” level in a dog still having frequent seizures may indicate need for a different drug, not just a higher dose.
- Ignoring sample timing relative to dosing — a level drawn 2 hours after dosing (peak) will be much higher than a trough level. Consistent sampling methodology is essential for meaningful comparison over time.
- Escalating dose before reviewing side-effect burden — if a dog is already sedated and ataxic at current levels, increasing the dose may worsen quality of life more than the remaining seizures do.
- Assuming “in range” automatically means clinically controlled — seizure control depends on individual threshold, not just population reference ranges. Some dogs achieve good control below the reference range; others require levels at the upper end.
Numbers support decisions; they do not replace clinical pattern review.
Your Seizure Log Is Your Most Important Tool
Track each event with:
- Date and time (exact, not approximate)
- Duration estimate (from start of motor activity to cessation)
- Cluster pattern (single event vs. multiple events within 24 hours)
- Recovery behavior (how long until the dog is ambulatory, eating, and behaving normally)
- Possible trigger context (was medication timing off? Was there a stressful event? Sleep disruption?)
- Video if possible — even 30 seconds of footage helps veterinary neurologists assess seizure type and severity
Poor logs create false assumptions about improvement or worsening. The difference between “seizures seem better” and “seizure frequency declined from 3/month to 1/month with unchanged severity” determines whether medication changes are appropriate.
When to Get Emergency Help Immediately
Call emergency services or your veterinarian immediately for:
- A seizure lasting more than 5 minutes (status epilepticus) — this is a life-threatening emergency requiring IV benzodiazepine administration
- Cluster episodes — two or more seizures within 24 hours, especially with incomplete recovery between events
- Severe post-ictal non-recovery — the dog remains disoriented, unable to stand, or unresponsive for more than 30-60 minutes
- Respiratory compromise or injury during or after a seizure
- First-ever seizure in a dog not previously diagnosed with epilepsy — initial seizures require urgent veterinary evaluation to identify potentially treatable causes
Have emergency instructions written before a crisis happens.
Other Conditions That Complicate Seizure Care
Long-term seizure care can overlap with other conditions that affect drug selection and monitoring:
- Seizures/epilepsy — the primary condition page
- Liver disease — phenobarbital hepatotoxicity risk requires enhanced monitoring; bromide may be preferred
- Kidney disease — affects bromide clearance and drug selection for polypharmacy
- Cognitive dysfunction — post-ictal cognitive changes can overlap with age-related cognitive decline, making assessment more complex
- Anxiety — seizure dogs often develop inter-ictal anxiety that itself requires management
Integrated review helps avoid avoidable adverse effects from drug interactions.
Breed and Age Context
Certain breeds have higher epilepsy prevalence and may present management complexity:
- Border Collie: high epilepsy prevalence with sometimes drug-resistant forms
- Australian Shepherd: elevated epilepsy risk with potential MDR1 drug sensitivity complicating drug selection
- Belgian Malinois: elevated epilepsy prevalence
- German Shepherd: moderate epilepsy risk with breed-specific seizure phenotypes
- Beagle: one of the best-characterized epilepsy models, often responsive to standard therapy
Use breed context as a risk prompt for earlier specialist referral, not a diagnostic conclusion.
Questions to Ask Your Vet
- “What level of seizure control is realistic for my dog?”
- “What side effects are acceptable versus unacceptable?”
- “What is our exact monitoring schedule for bloodwork and drug levels?”
- “Which signs mean same-day reassessment?”
- “When should we involve a veterinary neurology specialist?”
Frequently Asked Questions
Do seizure medications need regular bloodwork even if seizures improve?
Yes. Safety monitoring (liver enzymes, drug levels, thyroid function) is required regardless of seizure control quality. Phenobarbital can cause progressive hepatotoxicity that is detectable on bloodwork before clinical signs appear. Standard recommendation is every 6 months during stable maintenance.
Is one breakthrough seizure always a treatment failure?
Not always. Occasional breakthrough seizures may be acceptable within the defined treatment goals (50%+ frequency reduction with acceptable quality of life). Pattern assessment — considering severity, recovery quality, recent adherence, and trend direction — determines whether strategy changes are needed. A single mild seizure after 6 months of control is different from a cluster event with prolonged recovery.
What is the most important part of a seizure log?
Consistent date/time recording, accurate duration estimate, clustering pattern documentation, and post-event recovery description. Video recording, even brief clips, adds substantial diagnostic value for veterinary neurologists assessing seizure type and progression.
Can I adjust dose timing on my own if sedation is high?
Dose or timing changes should always be veterinarian-guided to avoid destabilization and safety risk. Even small changes to dosing intervals can alter steady-state drug levels and create breakthrough seizure risk. Discuss sedation concerns with your veterinarian, who may adjust the dose, change timing, or consider alternative medications.
When should I seek emergency care immediately?
Seek immediate care for seizures lasting more than 5 minutes, cluster events (two or more within 24 hours), severe post-ictal non-recovery lasting more than 60 minutes, respiratory compromise, or injury during a seizure. These situations require emergency veterinary intervention.
Bottom Line
Seizure medication success depends on structured monitoring, strict dosing adherence, and rapid escalation when patterns worsen. A detailed seizure log, clear emergency protocols, and regular bloodwork often improve outcomes more than frequent unsystematic therapy changes. Partner with your veterinarian to set realistic control goals and track progress objectively.
References
- Bhatt R et al. ACVIM Consensus Statement on seizure management in dogs and cats. JVIM. 2015.
- International Veterinary Epilepsy Task Force. Guidelines for treatment of canine epilepsy. JVIM. 2015.
- Podell M et al. 2015 ACVIM small animal consensus statement on seizure management in dogs. JVIM. 2016.
- Charalambous M et al. Antiepileptic drugs’ tolerability and safety: a systematic review of adverse effects in dogs. BMC Vet Res. 2016.